Stocks and Investing
Stocks and Investing
Tue, November 9, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Rick Bienkowski Maintained (BEAM) at Buy with Decreased Target to $116 on, Nov 9th, 2021
Rick Bienkowski of SVB Leerink, Maintained "Beam Therapeutics Inc." (BEAM) at Buy with Decreased Target from $117 to $116 on, Nov 9th, 2021.
Rick has made no other calls on BEAM in the last 4 months.
There is 1 other peer that has a rating on BEAM. Out of the 1 peers that are also analyzing BEAM, 0 agree with Rick's Rating of Hold.
This is the rating of the analyst that currently disagrees with Rick
- Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $150 on, Friday, September 10th, 2021
Contributing Sources